Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?

Hassan Izzedine¹, Marco Bonilla², Kenar D Jhaveri^{2

3}

Affiliations

¹ Department of Nephrology, Peupliers Private Hospital-Ramsay Générale de Santé, Paris, France.
² Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA.
³ The Glomerular Disease Center at Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and Northwell Health, Great Neck, NY, USA.

Hassan Izzedine et al. Nephrol Dial Transplant. 2021.

. 2021 Aug 27;36(9):1565-1569.

doi: 10.1093/ndt/gfab215.

Hassan Izzedine¹, Marco Bonilla², Kenar D Jhaveri^{2

3}

¹ Department of Nephrology, Peupliers Private Hospital-Ramsay Générale de Santé, Paris, France.
² Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA.
³ The Glomerular Disease Center at Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and Northwell Health, Great Neck, NY, USA.

No abstract available

References

1. Gutiérrez S, Dotto B, Petiti JP et al. Minimal change disease following influenza vaccination and acute renal failure: just a coincidence? Nefrologia 2012; 32: 414–415 - PubMed
1. Abeyagunawardena A, Goldblatt D, Andrews N et al. Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet 2003; 362: 449–450 - PubMed
1. Sahin U, Muik A, Derhovanessian E et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature 2020; 586: 594–599 - PubMed
1. Jackson LA, Anderson EJ, Rouphael NG et al. An mRNA vaccine against SARS-CoV-2—preliminary report. N Engl J Med 2020; 383: 1920–1931 - PMC - PubMed
1. Ewer KJ, Barrett JR, Belij-Rammerstorfer S et al.; Oxford COVID Vaccine Trial Group. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med 2021; 27: 270–278 - PubMed